Alterations in Microbial Diversity are Associated with Treatment Success with RBX2660, A Microbiota-Based Drug for the Prevention of Recurrent Clostridium Difficile Infection: Results from Punch CD 2, A Randomized Doubleblind Placebo-Controlled Trial

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Alterations in Microbial Diversity are Associated with Treatment Success with RBX2660, A Microbiota-Based Drug for the Prevention of Recurrent Clostridium Difficile Infection: Results from Punch CD 2, A Randomized Doubleblind Placebo-Controlled Trial
Authors
Keywords
-
Journal
GASTROENTEROLOGY
Volume 152, Issue 5, Pages S46-S47
Publisher
Elsevier BV
Online
2017-04-23
DOI
10.1016/s0016-5085(17)30518-8

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.